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Prefrontal cortex (PFC)-dependent functions, such as executive function, explicit
learning, and memory, are negatively affected in cocaine abusers and experimental
animal models of cocaine treatment. However, its molecular mechanisms are less
understood. In the present study, we performed transcriptome profiling of the dynamic
changes in the PFC after repeated cocaine administration in mice. We found 463, 14,
and 535 differentially expressed genes (DEGs) at 2 h, 24 h, and 7 days, respectively, after
the withdrawal of chronic cocaine treatment. Time-series correlation analysis identified
5 clusters of statistically significant expression patterns. The expression levels of DEGs
in Clusters 1 and 5 exhibited a gradual or fluctuant decrease, Cluster 2 exhibited an
initial increase followed by a decrease or return to the baseline level, and Clusters 3 and
4 exhibited a fluctuant increase in the expression of DEGs. The Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway analysis revealed that genes related to oxidative
phosphorylation, ribosomes, and neurodegenerative disorder were enriched in Cluster
1; genes related to the mitogen activated protein kinase (MAPK), transforming growth
factor (TGF)-β, insulin signaling, and circadian pathways were enriched in Cluster 2;
genes related to plasticity-related pathways were enriched in Clusters 3 and 4; and
genes related to the proteasome were enriched in Cluster 5. Our results suggest that
maladaptive neural plasticity associated with psychostimulant dependence may be an
ongoing degenerative process with dynamic changes in the gene network at different
stages of withdrawal. Furthermore, it could be helpful to develop new therapeutic
approaches according to different periods of abstinence.
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INTRODUCTION
Drug addiction is a chronic relapsing brain disease that is characterized by compulsive out-of-
control drug use, despite serious negative consequences (Pol bodetto et al., 2013). This behavioral
abnormality is caused by repeated exposure to a drug of abuse, and can potentially persist life-long
(Nestler, 2004). This persistence suggests that drug-induced maladaptive neural plasticity drives
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these long-term behavioral abnormalities, and changes of gene
expression in brain reward regions play important roles in this
process (Chao and Nestler, 2004; Nestler, 2004; Hyman et al.,
2006).
The mesolimbic dopamine system is generally considered
the most important mediator of drug reward, and cocaine has
a distinct effect on different anatomical regions in the brain.
Dopamine neurons are located in the ventral tegmental area
(VTA) of the midbrain and project to the limbic forebrain,
including the nucleus accumbens (NAc) and prefrontal cortex
(PFC), while the PFC sends glutamatergic efferents to the VTA
and NAc (Chao and Nestler, 2004). Cocaine has distinct effects
on these regions. The VTA-NAc circuit is the most intensively
studied region as it is thought to play an important role in the
initial rewarding effects of cocaine (Chao and Nestler, 2004),
while the roles of the PFC, an area critical for cognition and
executive functions, are less understood. It is suggested that
the PFC contributes to both the primary reinforcing effects of
cocaine and long-term sensitization to cocaine (Chao et al., 2014).
PFC-dependent functions, such as executive function, explicit
learning, andmemory were negatively affected in cocaine abusers
and experimental animal models of cocaine treatment (Chao
et al., 2014).
Over the past decade, many genes including various
membrane receptors, signal transduction molecules, and nuclear
genes, have been identified that drive addiction-related behaviors
(Palanza, 2001; Itzhak et al., 2014). However, most drug-
induced gene expression changes are very transient and do
not fully explain the long-lived alterations in addiction-related
behavior (Sen, 2014). It is suggested that the expression
or transient-differential-expression of many genes such as
immediate-early genes and transcription factors may affect the
expression of other genes, and it is of particular importance
to investigate gene expression long-after exposure to addictive
drugs (Jacobs et al., 2005). In addition, change in the
expression of most genes induced by exposure to addictive
drugs might have a specific spatiotemporal profile. In this
case, gene networks rather than individual genes are thought
to be altered, and therefore lead to more enduring neuro-
adaptations that drive structural plasticity to control additional
behaviors (Palanza, 2001; Chao et al., 2014; Itzhak et al.,
2014). Whole-genome gene expression profiles may help reveal
the complex gene-gene interaction mechanisms of addiction.
Thus, in the current study, we performed transcriptome
profiling of the mouse PFC to determine the dynamic
changes in this region after repeated cocaine treatment, to
understand long-lasting changes in the gene network after
cocaine administration.
MATERIALS AND METHODS
Cocaine Treatment and PFC Dissection
Adult male (10-week-old) C57BL/6 J mice (purchased
from HFK Bioscience Co., Ltd, Beijing, China) were
used in this study. Animals were habituated for at least
1 week in the new environment before experimentation.
They were housed 5 per cage, on a 12 h light-dark
cycle, and in a constant temperature environment
(21 ± 1◦C), with access to food and water ad
libitum.
All mice were randomly divided into cages, with five mice
per cage. Cocaine was dissolved in 0.9% saline. Repeated-cocaine
treatments is a popular paradigm to explore the mechanisms
of cocaine addiction. Consecutive intraperitoneal injections for
7 or 14 days are commonly used in previous studies, which
had been demonstrated neuroadaptational changes associated
with cocaine addition (Feng et al., 2014; Puig et al., 2014). In
the present study, animals received intraperitoneal injections
of cocaine (Qinghai Pharmacoceutical, China) at a dose of 20
mg/kg/d during 9:00 to 11:00 a.m. for 14 consecutive days. All
control groups received saline injections for 14 consecutive days.
Mice were asphyxiated using dry ice, and then the bilateral
PFC (0–1.5 mm from the tip of brain) was excised from each
animal individually at 2 h, 24 h, or 7 days after the final
injection of cocaine and then pooled randomly. The cortical
subregions in the excised tissue included frontal association
cortex, prelimbic cortex and orbital cortex. To account for inter-
animal variations, we obtained 2 biological replicates for each
treatment group, with each replicate representing the PFCs
pooled from 5 animals. The tissue was stored in liquid nitrogen
immediately and then transferred to −80◦C refrigerator. All
animal protocols were approved by the Review Board of the
Institute of Psychology, Chinese Academy of Sciences and were
performed strictly in accordance with the Guideline for Care
and Use of Laboratory Animals of the Chinese Academy of
Sciences.
RNA Sequencing and Functional
Enrichment Analysis
To characterize the transcriptome of the PFC, we used RNA
sequencing (RNA-seq) to measure the expression levels of
all polyA-containing transcripts in the PFC of mice treated
chronically with cocaine or saline (control).
RNA was extracted from PFC tissues using Trizol (Invitrogen,
Cat. 15596026) following themanufacturer’s instructions. Briefly,
50–100mg tissue was homogenized in 1 ml of TRIzol using
a homogenizer. RNA was separated by adding 0.2 ml of
chloroform per 1 ml of TRIzol reagent and then precipitated with
isopropanol. RNA quantified using a NanoDrop 2000 (Thermo-
Fisher Scientific, Waltham, MA, USA), and assessed with an
Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). The
RNA integrity number (RIN) of each sample was>8.
Total RNA (240–380 ng/ul, 2 ug) was used to prepare cDNA
libraries according to the manufacturer’s protocol (TruSeqTM
RNA Sample Prep Kit v2 -Set A, Illumina, San Diego, CA,
USA). The brief procedure of library preparation is as follows:
enrichment of mRNA by poly A, mRNA fragmentation, first
strand synthesis, second strand synthesis, end repair, A tailing,
adaptor ligation and PCR (13 cycle, 22.4–26.6 ng/ul× 30 ul).
Paired-end 100 nt sequencing was performed using the
Illumina HiSeq2000 (TruSeq PE Cluster Kit v3–cBot - HS and
TruSeq SBS Kit v3–HS). These 12 raw sequencing data sets
were deposited in the Gene Expression Omnibus of the NCBI
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(https://www.ncbi.nlm.nih.gov/geo) under accession number
GSE89572.
Bioinformatic Processing of the RNA-seq
Data
After removal of the adaptor sequences and trimming of low
quality sequences using cutadapt (Martin, 2011), all reads were
aligned to theUCSCmm9 version of themouse genome assembly
using the TopHat2 short read alignment program(Trapnell
et al., 2009). Only uniquely mapped reads were used in
this analysis. Fragments Per Kilobase of sequence per Million
mapped reads (FPKM) were used to normalize the number of
aligned reads by the size of the gene and the total number of
mapped reads. The changes in gene expression between different
groups were analyzed using the Cuﬄinks 2.0 package (Trapnell
et al., 2012). Cuﬄinks can estimate the relative abundances
of these transcripts based on how many reads support each
one, taking into account biases in library preparation protocols
(http://cole-trapnell-lab.github.io/cuﬄinks/manual/). Difference
in expression of genes with FDR (False Discovery Rate) value <
0.05 were considered as differentially expressed genes.
We identified statistically enriched functional terms from the
public databases of the KEGG Pathways (http://www.genome.jp/
kegg/pathway.html). Functional terms with FDR-value < 0.05
was considered as statistically significant enrichment.
Time-series clustering was performed to identify statistically
significant expression patterns and gene groups among
differentially expressed genes (DEGs) using the short time-series
expression miner (STEM; Ernst and Bar-Joseph, 2006). STEM
uses a method of analysis that takes advantage of the number
of genes being large and the number of time points being few
to identify statistically significant temporal expression profiles
and the genes associated with these profiles. User-defined
parameters were set to 35 profiles, maximizing the number of
clustering genes, with a minimum correlation threshold of 0.7.
Five statistically significant clusters were identified (p< 0.05).
Validation of Differentially Expressed
Genes (DEGs)
cDNA was synthesized from 1µg of total RNA (template) using
Superscript III (Invitrogen, CA, USA). The validation of DEGs
were determined by real-time quantitative PCR using SYBR
Green Mix (CWBIO, Beijing, China). PCR conditions were:
95◦C for 10 min, 40 cycles at 95◦C for 10 s, 60◦C for 60
s, and signal detection for 10 s; dissociation curve analysis
was performed at the end of each run, and relative mRNA
expression was determined by the standard ∆∆Ct method
using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
a normalization control. The primers are listed in Table S1.
Data Analysis
Statistical analyses were performed with GraphPad Prism 6.0
software. Means of relative gene expression between two groups
were compared with a two-tailed Student’s t-test. Statistical
significance was set at p< 0.05.
RESULTS
Quality Assessment of the Sequenced Data
We obtained 36, 913, 048 to 50, 325, 962 short reads of 100 bp
from each replicate from both the cocaine treated and control
animals. Of these, 84–87.08% were successfully aligned to a
reference gene database (Ensembl: Mus musculus, NCBI) by
TopHat (Trapnell et al., 2009).
Overview of the DEGs
For our initial analysis, we used stringent false discovery rate
(FDR) cutoffs of< 0.05. As showed in Figure 1, we obtained 463,
14, and 535 DEGs from samples obtained 2 h, 24 h, and 7 days
after the final administration of cocaine, respectively (corrected p
< 0.05). Among of them, there were 62/401 (2 h), 3/11 (24 h), and
311/224 (7 d) DEGs with decreased/increased expression level,
respectively (Tables S2, S3 and S4). Only 4 DEGs were shared by
all 3 time points, namely Dusp6, Fos, Nr4a1, and Egr1 (Figure 1).
Through functional enrichments of DEGs, several signaling
pathways were enriched at each of the time points (Table 1). Two
categories of signaling pathways were enriched (corrected p <
0.05) at 2 h. The first category comprised the signaling pathways
regulating cell division, cell differentiation, and cell death, e.g.,
the Wnt signaling pathway, mitogen activated protein kinase
(MAPK) signaling pathway, and Jak-STAT signaling pathway.
The second enriched pathway was related to the circadian
rhythm. Even though the number of DEGs was greatly decreased
after 24 h of withdrawal, the circadian rhythm and MAPK
signaling pathway were significantly enriched. At the 7 days
post-withdrawal time-point, the number of DEGs was increased;
FIGURE 1 | Venn map of DEGs from different withdrawal time: subsets
of significant changes by Tukey’s HSD comparison. The numbers within
each segment indicate the number of DEGs of different withdrawal time points.
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TABLE 1 | Distinct pathways involved in different stages of withdrawal
after chronic cocaine treatment.
2 h after final cocaine administration
# Pathway FDR Pathway ID
1 Pathways in cancer 0.005854 ko05200
2 Circadian rhythm - mammal 0.005854 ko04710
3 Adherens junction 0.006437 ko04520
4 Circadian rhythm - fly 0.011379 ko04711
5 Jak-STAT signaling pathway 0.011575 ko04630
6 Melanogenesis 0.029236 ko04916
7 Wnt signaling pathway 0.029236 ko04310
8 MAPK signaling pathway 0.029236 ko04010
24 h after final cocaine administration
# Pathway FDR Pathway ID
1 Circadian rhythm - mammal 0.00279 ko04710
2 MAPK signaling pathway 0.013751 ko04010
3 Circadian rhythm - fly 0.030747 ko04711
7 days after final cocaine administration
# Pathway FDR Pathway ID
1 Oxidative phosphorylation 4.86E-32 ko00190
2 Ribosome 3.71E-31 ko03010
3 Parkinson’s disease 5.02E-27 ko05012
4 Huntington’s disease 1.70E-26 ko05016
5 Alzheimer’s disease 2.96E-24 ko05010
6 Proteasome 2.00E-07 ko03050
7 Cardiac muscle contraction 3.95E-06 ko04260
8 Vibrio cholerae infection 2.19E-05 ko05110
9 Metabolic pathways 2.63E-05 ko01100
10 Rheumatoid arthritis 0.001783 ko05323
11 Epithelial cell signaling in
Helicobacter pylori infection
0.001876 ko05120
12 Collecting duct acid secretion 0.004512 ko04966
13 RNA polymerase 0.007616 ko03020
14 Citrate cycle (TCA cycle) 0.008566 ko00020
15 Protein export 0.009591 ko03060
16 Gastric acid secretion 0.011006 ko04971
17 Salivary secretion 0.015994 ko04970
18 Vascular smooth muscle contraction 0.016231 ko04270
19 Aldosterone-regulated sodium
reabsorption
0.028328 ko04960
20 Long-term potentiation 0.035467 ko04720
*FDR mean “false discovery rate.”
however, most of these genes were significantly enriched (FDR
< 0.01) in metabolic pathways, for example, the electron
transport chain, ribosomes, proteasomes, citrate cycle, and RNA
polymerase. These results indicate that distinct pathways are
involved in the acute, sub-acute, and long-lasting stages of
withdrawal after chronic cocaine treatment.
Clusters from Stem Analysis and Their
KEGG Pathway Analysis
To further utilize the dynamic expression information, we
performed time-series correlation analysis on the total DEGs of
all 3 time points using the STEM method, which produced 5
clusters of DEGs with significant serial correlation of expression
changes (r > 0.7; p < 0.05). Among them, the expression
levels of DEGs in Cluster 1 gradually decreased with time,
while those in Cluster 2 first increased and then decreased
or returned to the baseline level (the same level as those
in the saline group). Expression changes in Cluster 3 and
Cluster 4 shared a similar pattern of fluctuation, with an
initial increase followed by a decrease and then finally another
increase. Whereas, expression levels of DEGs in Cluster 5
initially decreased, then increased, and decreased again at the end
(Figure 2).
Clusters 1 and 5: Gradual or Fluctuant
Decrease
There were 3 sub-clusters in Cluster 1 that were consistent
with the general tendency of gradual or fluctuant decrease,
as shown in Figures 2A, 3A. The most highly enriched
pathways in Cluster 1 were oxidative phosphorylation, and
neurodegenerative disorders such as Huntington’s disease,
Parkinson’s disease, and Alzheimer’s disease. In addition,
the oxidative phosphorylation chain and proteasome
were significantly enriched in both Clusters 1 and 5
(Figures 2E, 3E).
Cluster 2: Initial Increase Followed by a
Decrease or Return to the Baseline
There were 3 sub-clusters in Cluster 2 as showed in Figures 2B,
3B. KEGG pathway analysis of genes within Cluster 2 showed
that the MAPK signaling pathway, the p53 pathway, TGF-
β signaling pathway, insulin-signaling pathway, and circadian
pathway were significantly enriched.
Clusters 3 and 4: Fluctuant Increase
Clusters 3 and 4 (Figures 2C,D, 3C,D) shared a similar pattern
of changes in the expression of DEGs, an initial increase followed
by a decrease and then finally an increase. KEGG pathway
analysis of Clusters 3 showed that they were mainly enriched in
plasticity-related pathways, such as long-term potentiation and
the regulation of the actin cytoskeleton, while axon guidance was
enriched in both Clusters 3 and 4.
Validation of RNA-seq Data by qRT-PCR
We validated these RNA-seq data independently from tissue
samples using qRT-PCR. As shown in Table 2, we identified
the expression of 10 genes at 3 different withdrawal time
points, with 83.3% of genes/time points showing consistent
results. Some of validated genes have been widely studied on
their effects on cocaine exposure, while others have known
functions, which may contribute to drug addiction. Fosb encoded
∆FosB, a truncated and stable protein, which is a well-
characterized transcription factor induced by chronic exposure
to virtually all drugs of abuse (Wallace et al., 2008). Nr4a1
increases in frontal cortex (Freeman et al., 2002) and Nr4a3
increases in the medial caudate putamen and cingulate cortex
(Werme et al., 2000) after chronic cocaine administration. Nr4a2
plays an important role in development and differentiation of
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FIGURE 2 | Correlated expression Clusters and their sub-clusters discovered using the short time series expression miner (STEM) algorithm for time
series profile matching: (A): Cluster 1 and its sub-cluster; (B): Cluster 2 and its sub-cluster; (C): Cluster 3 and its sub-cluster; (D): Cluster 4 and its sub-cluster;
(E): Cluster 5 and its sub-cluster. Different colors within each sub-cluster represented different genes. Values are the mean Log2(fold change) values as compared to
sacrifice-time matched control animals.
midbrain DA neurons and Nr4a2 gene expression decreased
in human post-mortem midbrain of cocaine abusers (Leo
et al., 2007). Our results further demonstrated that Nr4a1
persistently increased while Nr4a2 and Nr4a3 showed transient
changes after cocaine withdrawal, indicating their different
roles in different stages of cocaine addiction. The roles
of Wnt pathway in the NAc in long-term cocaine-induced
neuroplasticity have been reported (Cuesta et al., 2017). Notch
signaling is an important regulator of neuronal homeostasis and
Notch1 activation is involved in cocaine-mediated regulation of
PDGF-B expression (Yao et al., 2011). In the present study, we
found both Wnt4 and Notch2 expression increased 2 h after
withdrawal and their roles in cocaine addiction should be further
investigated. Cocaine-induced histone methylation at many
specific candidate genes is already known (11).We foundKdm6b,
a histone demethylase, increased 7d after cocaine withdrawal,
indicating its potential role in cocaine addiction for the first
time.
DISCUSSION
In the current study, we observed dynamic changes in the
transcriptome profiling of the PFC of repeated-cocaine treated
mice, and found that distinct pathways were involved in the
acute, sub-acute, and chronic stages of withdrawal. The main
findings of our results include: (1) energymetabolism and protein
metabolism pathways showed gradual or fluctuant decrease after
cocaine withdrawal; (2) ERK pathway showed persistent changes
after cocaine withdrawal; (3) plasticity related pathways, such as
long-term potentiation, the regulation of the actin cytoskeleton,
and the axon guidance pathway, showed a fluctuant increase after
cocaine withdrawal.
Dynamic Decrease of Energy Metabolism
and Protein Metabolism Pathways
Mitochondrial energy production, which occurs through
oxidative phosphorylation, requires the action of various
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FIGURE 3 | Functional annotation of DEGs of Time series clusters by KEGG pathways. (A) Functional annotation of DEGs of cluster 1; (B): Functional
annotation of DEGs of cluster 2; (C): Functional annotation of DEGs of cluster 3; (D): Functional annotation of DEGs of cluster 4; (E): Functional annotation of DEGs of
cluster 5. The length of the bar represent the number of gene involved in the pathway.
respiratory complexes together known as the electron
transport chain enzymes (ETC). There are 5 ETC complexes:
(i) Complex I (NADH dehydrogenase), (ii) Complex II
(succinate dehydrogenase), (iii) Complex III (cytochrome bc1
complex), (iv) Complex IV [cytochrome c oxidase (COX)],
and (v) Complex V (ATP synthase). Our results found that
over 40 genes in the PFC involved in each ETC complex
were gradual or fluctuant decrease after cocaine-withdrawal,
indicating that energy metabolism impairment induced by
repeated-cocaine treatment showed a time-dependent increase
following withdrawal. Studies in humans, nonhuman primates,
and mice have demonstrated cocaine-associated reductions in
metabolic activity in the brain. By testing the regional cerebral
metabolic rate for glucose, it was found that 10 or 14 days
of repeated daily treatment decreased metabolic activity in
the mesolimbic dopaminergic pathway, including the PFC
(Hammer and Cooke, 1994). The glucose metabolism rate
and blood flow significantly decreased in the PFC of cocaine
addicts, indicating lower metabolism and activity in brain
of cocaine abusers (Goldstein and Volkow, 2002; Volkow
et al., 2004). At the molecular level, both metabolic proteins
in cocaine addicts and mitochondrial proteins in animal
model of cocaine abuse are decreased (Lull et al., 2008). Our
results further showed a dynamic metabolic decrease after
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TABLE 2 | Comparison of RNA-seq and RT-PCR.
Gene RNA-Seq RT-PCR
2 h 24 h 7 d 2 h 24 h 7 d
JunB 5.4* 1.67 1.38* 3.70* 1.37 1.66*
Nr4a1 4.53* 1.62* 1.51* 4.37* 2.36* 1.29*
Nr4a2 2.03* 1.7 1.32 1.40* 1.26 1.36
Nr4a3 3.01* 1.69 1.18 2.10* 1.14 0.99
Kdm6b 1.00 1.17 1.18 1.16 1.17 1.31*
Notch1 1.36 1.07 1.22 1.01 0.87 1.18
Notch2 1.43* 0.92 1.33 0.88 0.81 1.01
Wnt4 1.33* 1.23 1.14 1.08 1.07 0.84
Wnt7b 1.03 1.004 1.005 0.69* 0.95 0.73
Grin2b 1.09 0.96 1.38* 0.92 0.83 1.25
*p < 0.05 compared with saline control.
cocaine withdrawal and suggest that this gradual decrease
could represent an adaption of the metabolic response to
cocaine in the PFC. A recent study found that compulsive
drug-seeking behavior induced by repeated cocaine treatment
resulted from reduced pyramidal cell excitability mediated
by PFC metabolic dysfunction (Chen et al., 2013). Here, we
revealed changes of the energy metabolism network underlying
repeated cocaine treatment and believe that an adaption
of the metabolic response to cocaine in the PFC may be
another important mechanism of relapse during protracted
abstinence.
Dynamically decreased genes were also enriched in the
proteasome pathway, including the subunits composing the core
particle of proteasomes during ubiquitin-mediated proteolysis.
The ubiquitin proteasome system (UPS) controls the degradation
of misfolded, newly synthesized proteins, as well as the turnover
of specific target proteins. Consistent with our results, many
transcriptomic and proteomic studies have described the effects
of treatment with drugs of abuse on proteasome subunits
or proteins involved in the ubiquitination process (Massaly
et al., 2014). In the case of cocaine treatment, ubiquitin-
conjugating enzyme E2N and proteasome subunit-alpha type 2
were involved in cocaine-conditioned place preference (Guan
and Guan, 2013). Interestingly, it is suggested that synaptic
and signaling proteins, especially transcription factors, which
mediate enduring neuronal plasticity, could be regulated directly
or indirectly by a UPS-dependent process (Massaly et al.,
2014). Combined with lasting changes in transcription factors
such as Nr4a1, Fos, and Egr1 in our results, we speculate
that UPS-dependent regulation plays an important role in
neuronal plasticity associated with the long-term effect of
cocaine.
ERK Pathway Showed Persistent Changes
after Cocaine Withdrawal
The MAPK pathway is one of the most conserved signaling
pathways in eukaryotes. Multiple proteins involved in
this pathway transfer extracellular biological, chemical,
or physical signals into the cell by adding or removing
adjacent phosphate groups of the protein molecule(Roux
and Blenis, 2004). The MAPK signal pathway is divided
into 3 sub-pathways: the ERK (extracellular signal-regulated
kinase), JNK (c-Jun NH2-terminal kinase), and p38 signal
pathways (Roux and Blenis, 2004). Four genes, phosphorylase
Dusp6, and transcription factors Egr1, Fos, and Nr4a1,
which all belong to the ERK signaling pathway, showed
a persistent expression change after cocaine withdrawal
(Table 3).
Several lines of evidence have demonstrated the important
roles of the ERK pathway in cocaine addiction. Both acute
and repeated injections of cocaine activated ERK in the
mesolimbic reward system, including the VTA, PFC, bed
nucleus of the stria terminalis, and amygdala (Lu et al., 2006).
In addition, ERK contributes to various behavioral effects
of cocaine, such as psychomotor sensitization, conditioned
place preference, and reconsolidation of memories for cocaine
cues (Lu et al., 2006). Importantly, long-lasting changes of
the ERK pathway induced by repeated cocaine treatment
have been supported by the association of long-term ERK-
mediated effects and ERK-dependent activation of FOS and
EGR1 (Radwanska et al., 2005). High rates of relapse to
cocaine use in humans after prolonged abstinence indicated
that the drug-induced adaptation in cellular mechanisms was
persistent during abstinence (Lu et al., 2004). A time-dependent
increase in cocaine seeking induced by cocaine cues involves
activation of ERK signaling, suggesting this pathway mediates
the incubation of cocaine craving (Lu et al., 2005). Together,
we suggest that long-lasting changes of the ERK signaling
pathway in the PFC induced by cocaine treatment may be
one of the most important mechanisms underlying cocaine
addiction.
Fluctuant Activity of Plasticity-Related
Pathways After Cocaine Withdrawal
In the present study, we found that long-term potentiation (LTP),
the regulation of the actin cytoskeleton, and the axon guidance
pathway demonstrated fluctuant changes after withdrawal of
repeated cocaine treatment, consistent with the current opinion
that during abstinence, neuroplasticity at many levels, ranging
from cellular alterations tomorphological and structural changes,
plays an essential role in addictive behaviors (Kasanetz et al.,
2012; Nyberg, 2014). Repeated cocaine exposure modifies the
induction of tetanus-induced LTP in vitro and in vivo, which was
associated with dysfunction of glutamate receptors (Yao et al.,
2004; Goto and Grace, 2005). The actin cytoskeleton has been
shown to promote presynaptic vesicle movement, postsynaptic
glutamate receptor trafficking, and morphogenesis of dendritic
spines (Nyberg, 2014). In addition, changes in dendritic spine
diameter and density due to chronic cocaine administration
were associated with a deteriorating actin cytoskeleton and
reduction in glutamate signaling-related proteins (Shen et al.,
2009). However, alterations of drug-induced synaptic plasticity
were guided by molecular cues, such as axon guidance molecules,
that form projection-target connections during rearrangement of
the synapse (Bahi and Dreyer, 2005). Together with these results,
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TABLE 3 | DEGs involved in the MAPK signal pathway.
Withdrawal time Pathway ERK p38 JNK
2 h A.S./Receptor Pdgfb/Cacnb1 – –
MAPKKK – Gadd45 –
MAPKK – – Crk1
MAPK/MAPK Phosphatase Dusp1, Dusp4, Dusp5, Dusp6 p38/Dusp1, Dusp4, Dusp5, Dusp6 Dusp1, Dusp4, Dusp5, Dusp6
Downstream effectors Mknk2, Rps6ka2, Fos, Nr4a1 Hsp27 –
24 h A.S./Receptor – – –
MAPKKK – – –
MAPKK – – –
MAPK/MAPK Phosphatase Dusp6 Dusp6 Dusp6
Downstream effectors Fos, Nr4a1 – –
7 d A.S./Receptor Fgfr3 – –
MAPKKK Prkcb (PKC) – –
MAPKK – – –
MAPK/MAPK Phosphatase Dusp1, Dusp6 Dusp1, Dusp6 Dusp1, Dusp6
Downstream effectors Stmn1, Fos, Nr4a1 – –
our findings indicate that potential associations among these
varied levels of neuroplasticity play an important role in cortical
reorganization after withdrawal of repeated cocaine treatment.
Common and Different Changes of Gene
Expression in Cocaine Responds Across
Different Brain Regions
Previous studies suggest that circadian genes, including Per1,
Per2, and Npas2 in NAc and hippocampus play roles in
modulating cocaine reward or sensitization (Abarca et al., 2002;
Imbesi et al., 2009). In dorsal striatum, >20% (29 genes total)
were identified as genes associated with the circadian system
in a total of 139 genes, which were regulated by cocaine self-
administration (Lynch et al., 2008). Together with our findings of
circadian pathway enrichment in the PFC after repeated cocaine
treatment, it is indicated that circadian genes play essential roles
in cocaine addiction regardless of treatment paradigm or brain
regions.
As mentioned above, MAPK pathway also plays important
roles in cocaine addiction across different brain regions. There
is evidence indicating that MAPKs have roles in the circadian
biological clock. MAPK signaling pathways and circadian clocks
affect similar biological processes and defects in either pathway
lead to many of the same types of human diseases (Goldsmith
and Bell-Pedersen, 2013). Interestingly, our further analysis
showed that MAPK and circadian pathway had similar dynamic
changes after cocaine withdrawal (r > 0.70, p < 0.05), indicating
that interaction between these two pathways mediated cocaine-
induced neuroadaptations.
On another hand, a study compared changes of genes
expression with cocaine abstinence between the mPFC and NAc
(Freeman et al., 2010). The results showed that only a limited
number of changes were observed in both brain regions. Another
study showed that genes involved in cholinergic, glutamatergic,
and GABAergic signaling transmissions in NAc were in response
to chronic cocaine exposure and withdrawal (Eipper-Mains et al.,
2013). In our study, only a few neurotransmitter receptors such
as Grin2a and Grin2b, were changed in the PFC 7d after cocaine
withdrawal. These inconsistent results may reflect distinct roles
of genes in different brain regions. In addition, different cocaine
treatment paradigms may contribute to these differences. For
example, repeated cocaine treatment resulted in different changes
of gene network with or without locomotor sensitization test
(Eipper-Mains et al., 2013; Feng et al., 2014).
Repeated exposure to cocaine leads to sensitization, and may
persist for weeks to years after cessation of drug taking, which
may contribute to drug relapse (Hyman et al., 2006). Our finding
indicates that maladaptive neural plasticity after repeated cocaine
treatment is an ongoing, degenerative process with dynamic
changes of the gene network at different stages of withdrawal. The
long-lasting adverse effects on neuropsychiatric impairments that
persist following abstinence lead to poor treatment outcomes.
Understanding the dynamic profile of gene expression after
abstinence could be helpful in developing new therapeutic
approaches according to different periods of abstinence.
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